Petros Pharmaceuticals, Inc. (29) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
Amendment No. 1 to License and Commercialization Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
(Filed With SEC on May 16, 2022)
-
Amendment No. 1 to License and Commercialization Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
(Filed With SEC on January 21, 2022)
-
License Agreement, dated as of March 14, 2020, by and between the Company and Hybrid Medical LLC
(Filed With SEC on March 31, 2021)
